Sector Outlook 2023: Rajiv Gandhi, CEO & MD Of Hester Biosciences On Hester Acquires Technology- From ICAR

Hester Biosciences to make vaccine for new strain of Bird Flu. ICAR-NIHSAD has transferred technology. What is the outlook for the new year? Watch Swati Khandelwal's exclusive interview with Hester Biosciences, CEO & MD, Rajiv Gandhi.